Hypertonic sodium choloride and mannitol induces COX-2 via different signaling pathways in mouse cortical collecting duct M-1 cells

Life Sciences

Volumn 80, Issue 22, 2007, Pages 2085-2092

  Lim, WonChung ^a,d   Jung, JinSup ^b,d   Surh, YoungJoon ^c,d   Inoue, Hiroyasu ^c,d   Lee, YoungJoo ^a,d  

^a Institute of Biotechnology   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2; Hypertonicity; Kidney cortical collecting duct; NF B

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOHEXIMIDE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; HYPERTONIC SOLUTION; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; SODIUM CHLORIDE; ENZYME INHIBITOR; MESSENGER RNA; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME SYNTHESIS; HYPEROSMOTIC STRESS; KIDNEY; KIDNEY COLLECTING TUBULE; MOUSE; NONHUMAN; POINT MUTATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL LINE; CYCLOOXYGENASE 2; ENZYME INDUCTION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KIDNEY TUBULES, COLLECTING; MANNITOL; MICE; RNA, MESSENGER; SALINE SOLUTION, HYPERTONIC; SIGNAL TRANSDUCTION; SODIUM CHLORIDE; TRANSCRIPTION FACTOR RELA;

EID: 34247557479     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.03.014     Document Type: Article

References (42)

1. Bladh L.G., Liden J., Dahlman-Wright K., Reimers M., Nilsson S., and Okret S. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression. Molecular Pharmacology 67 3 (2005) 815-826
2. Breyer M.D. Regulation of renal function by prostaglandin E receptors. Kidney International. Supplement 67 (1998) S88-S94
3. Chen G., Wood E.G., Wang S.H., and Warner T.D. Expression of cyclooxygenase-2 in rat vascular smooth muscle cells is unrelated to nuclear factor-kappaB activation. Life Sciences 64 14 (1999) 1231-1242
4. Chen J., Zhao M., Rao R., Inoue H., and Hao C.M. C/EBP{beta} and its binding element are required for NF{kappa}B-induced COX2 expression following hypertonic stress. Journal of Biological Chemistry 280 16 (2005) 16354-16359
5. Cheng H.F., Wang J.L., Zhang M.Z., Mckanna J.A., and Harris R.C. Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. Journal of Clinical Investigation 106 5 (2000) 681-688
6. Cheng H.F., and Harris R.C. Cyclooxygenase-2 expression in cultured cortical thick ascending limb of Henle increases in response to decreased extracellular ionic content by both transcriptional and post-transcriptional mechanisms. Role of p38-mediated pathways. Journal of Biological Chemistry 277 47 (2002) 45638-45643
7. Dean J.L., Brook M., Clark A.R., and Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. Journal of Biological Chemistry 274 1 (1999) 264-269
8. Dewitt D.L., and Meade E.A. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. Archives of Biochemistry and Biophysics 306 1 (1993) 94-102
9. Evett G.E., Xie W., Chipman J.G., Robertson D.L., and Simmons D.L. Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: regulation by dexamethasone, mitogens, and oncogenes. Archives of Biochemistry and Biophysics 306 1 (1993) 169-177
10. Ferguson S., Hebert R.L., and Laneuville O. NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line. Journal of the American Society of Nephrology 10 11 (1999) 2261-2271
11. Folzenlogen S.L., Novak J., and Banks R.O. Renal actions of endothelin during mannitol and saline expansion. Proceedings of the Society for Experimental Biology and Medicine 200 3 (1992) 378-382
12. Hao C.M., Yull F., Blackwell T., Komhoff M., Davis L.S., and Breyer M.D. Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. Journal of Clinical Investigation 106 8 (2000) 973-982
13. Hendrickx N., Volanti C., Moens U., Seternes O.M., de Witte P., Vandenheede J.R., Piette J., and Agostinis P. Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. Journal of Biological Chemistry 278 52 (2003) 52231-52239
14. Holbeck S., Bentzer P., and Grande P.O. Effects of hypertonic saline, mannitol, and urea with regard to absorption and rebound filtration in cat skeletal muscle. Critical Care Medicine 30 1 (2002) 212-217
15. Howe L.R., Subbaramaiah K., Brown A.M., and Dannenberg A.J. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocrine-Related Cancer 8 2 (2001) 97-114
16. Inoue H., Yokoyama C., Hara S., Tone Y., and Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. Journal of Biological Chemistry 270 42 (1995) 24965-24971
17. Inoue H., Umesono K., Nishimori T., Hirata Y., and Tanabe T. Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochemical and Biophysical Research Communications 254 2 (1999) 292-298
18. Jones D.A., Carlton D.P., McIntyre T.M., and Zimmerman G.A. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. Journal of Biological Chemistry 268 12 (1993) 9049-9054
19. Junger H., Edelman D.B., and Junger W.G. Hypertonicity promotes survival of corticospinal motoneurons via mitogen-activated protein kinase p38 signaling. Journal of Molecular Neuroscience 21 2 (2003) 111-120
20. Korbmacher C., Segal A.S., Fejes-Toth G., Giebisch G., and Boulpaep E.L. Whole-cell currents in single and confluent M-1 mouse cortical collecting duct cells. Journal of General Physiology 102 4 (1993) 761-793
21. Korus M., Mahon G.M., Cheng L., and Whitehead I.P. p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr. Oncogene 21 30 (2002) 4601-4612
22. Kujubu D.A., Reddy S.T., Fletcher B.S., and Herschman H.R. Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. Journal of Biological Chemistry 268 8 (1993) 5425-5430
23. Lim W.C., Park M., Bahn J.J., Inoue H., and Lee Y.J. Hypertonic sodium chloride induction of cyclooxygenase-2 occurs independently of NF-kappaB and is inhibited by the glucocorticoid receptor in A549 cells. FEBS Letters 579 24 (2005) 5430-5436
24. Madrid L.V., Mayo M.W., Reuther J.Y., and Baldwin Jr. A.S. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. Journal of Biological Chemistry 276 22 (2001) 18934-18940
25. Mitchell J.A., Saunders M., Barnes P.J., Newton R., and Belvisi M.G. Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid. Molecular Pharmacology 51 6 (1997) 907-912
26. Moeckel G.W., Zhang L., Fogo A.B., Hao C.M., Pozzi A., and Breyer M.D. COX2 activity promotes organic osmolyte accumulation and adaptation of renal medullary interstitial cells to hypertonic stress. Journal of Biological Chemistry 278 21 (2003) 19352-19357
27. Natke Jr. E. Cell volume regulation of rabbit cortical collecting tubule in anisotonic media. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology F1657-F1665 6 (1990) 258
28. Newton R., Hart L., Chung K.F., and Barnes P.J. Ceramide induction of COX-2 and PGE(2) in pulmonary A549 cells does not involve activation of NF-kappaB. Biochemical and Biophysical Research Communications 277 3 (2000) 675-679
29. Park S.W., Sung M.W., Heo D.S., Inoue H., Shim S.H., and Kim K.H. Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines. Oncogene 24 44 (2005) 6689-6698
30. Pingle S.C., Mishra S., Marcuzzi A., Bhat S.G., Sekino Y., Rybak L.P., and Ramkumar V. Osmotic diuretics induce adenosine A1 receptor expression and protect renal proximal tubular epithelial cells against cisplatin-mediated apoptosis. Journal of Biological Chemistry 279 41 (2004) 43157-43167
31. Rao R., Hao C.M., and Breyer M.D. Hypertonic stress activates glycogen synthase kinase 3beta-mediated apoptosis of renal medullary interstitial cells, suppressing an Nfkappa B-driven cyclooxygenase-2-dependent survival pathway. Journal of Biological Chemistry 279 6 (2004) 3949-3955
32. Ridley S.H., Dean J.L., Sarsfield S.J., Brook M., Clark A.R., and Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Letters 439 1-2 (1998) 75-80
33. Roger F., Martin P.Y., Rousselot M., Favre H., and Feraille E. Cell shrinkage triggers the activation of mitogen-activated protein kinases by hypertonicity in the rat kidney medullary thick ascending limb of the Henle's loop. Requirement of p38 kinase for the regulatory volume increase response. Journal of Biological Chemistry 274 48 (1999) 34103-34110
34. Sansom S.C., La B.Q., and Carosi S.L. Double-barreled chloride channels of collecting duct basolateral membrane. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology 259 1 (1990) F46-F52
35. Saunders M.A., Sansores-Garcia L., Gilroy D.W., and Wu K.K. Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts. Journal of Biological Chemistry 276 22 (2001) 18897-18904
36. Smith W.L., Garavito M., and Dewitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. Journal of Biological Chemistry 271 52 (1996) 33157-33160
37. + pump inhibition in CCT principal cells. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology 260 2 (1991) F225-F234
38. Subbaramaiah K., Norton L., Gerald W., and Dannenberg A.J. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. Journal of Biological Chemistry 277 21 (2002) 18649-18657
39. Sun A., and Hebert S.C. Rapid hypertonic cell volume regulation in the perfused inner medullary collecting duct. Kidney International 36 5 (1989) 831-842
40. Volk T., Fromter E., and Korbmacher C. Hypertonicity activates nonselective cation channels in mouse cortical collecting duct cells. Proceedings of the National Academy of Sciences of the United States of America 92 18 (1995) 8478-8482
41. Yang T., Huang Y., Heasley L.E., Berl T., Schnermann J.B., and Briggs J.P. MAPK mediation of hypertonicity-stimulated cyclooxygenase-2 expression in renal medullary collecting duct cells. Journal of Biological Chemistry 275 30 (2000) 23281-23286
42. Zhao H., Tian W., Tai C., and Cohen D.M. Hypertonic induction of COX-2 expression in renal medullary epithelial cells requires transactivation of the EGFR. American Journal of Physiology. Renal, Fluid and Electrolyte Physiology 285 2 (2003) F281-F288